Marshall Wace, LLP Generation Bio Co. Transaction History

Marshall Wace, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.91 - $3.35 $81,093 - $298,531	89,114 Added 258.5%	123,587 $203,000
Q4 2022 Feb 14, 2023	BUY	$3.66 - $6.77 $2,382 - $4,407	651 Added 1.92%	34,473 $135,000
Q3 2022 Nov 14, 2022	SELL	$4.68 - $8.34 $3,046 - $5,429	-651 Reduced 1.89%	33,822 $180,000
Q1 2022 May 16, 2022	SELL	$4.16 - $7.76 $83,183 - $155,168	-19,996 Reduced 36.71%	34,473 $253,000
Q4 2021 Feb 14, 2022	BUY	$5.99 - $24.97 $103,405 - $431,057	17,263 Added 46.4%	54,469 $385,000
Q3 2021 Nov 15, 2021	SELL	$20.0 - $27.43 $1.48 Million - $2.03 Million	-74,124 Reduced 66.58%	37,206 $933,000
Q2 2021 Aug 13, 2021	BUY	$24.34 - $38.34 $2.71 Million - $4.27 Million	111,330 New	111,330 $3 Million

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $79.7M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.